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INTRODUCTION 
Salmonellosis is one of the most important 
bacterial zoonotic diseases and represents a 
considerable burden to humans in both 
developing and developed countries1. The 
consumption of contaminated pork is a major 
source of Salmonella Typhimurium infections 
in humans. Porcine carcass contamination is 
correlated with long-term Salmonella 
persistence in pigs, resulting in so called 
asymptomatic ‘carrier pigs’. Since 
interference of several pathogens with the 
host’s immune system has already been 
shown to be of major importance for 
successful long-term infection2, Salmonella 
Typhimurium persistence in pigs could be the 
result of the bacterium being able to 
circumvent the host’s cellular and/or humoral 
immune responses. It was the aim of the 
present study to examine if, how and why 
Salmonella Typhimurium escapes the porcine 
humoral immune system. 
 
METHODS AND MATERIALS 
As wild type we used a virulent Salmonella 
Typhimurium phage type 120/Ad strain, 
isolated from a pig stool sample. An sseA (a 
SPI-2 effector) deletion mutant was created 
as described by Datsenko and Wanner3. Both 
strains were GFP-transformed for use in flow 
cytometry. In an in vivo trial, blood samples 
of 17 Salmonella-negative piglets were 
collected before and 2 and 4 weeks after oral 
inoculation with 2 x 107 colony forming units 
(CFU) wild type Salmonella Typhimurium. 
Samples were examined for the presence of 
Salmonella-specific antibodies using a 
commercially available Elisa (IDEXX 
Laboratories). Pig antisera for opsonization 
experiments were raised from pigs either 
injected intramuscularly with formalin 
inactivated in Freunds incomplete adjuvant 
wild type Salmonella Typhimurium or PBS, 
resulting in serum with and without  
 Salmonella-specific antibodies respectively. 
For opsonization experiments, wild type 
bacteria were incubated with an equal 
volume of pig serum with or without 
Salmonella-specific antibodies on a shaker. 
Primary porcine alveolar macrophages 
(PAM) were collected through broncho-
tracheal washes as described previously4. 
The washes were centrifuged and 
macrophage pellets were washed 3 times 
with HBSS (Gibco Life Technologies) and 
stored in foetal calf serum (Gibco Life 
Technologies) with 10% DMSO (Sigma 
Aldrich) in liquid nitrogen. For infection 
experiments, PAM were seeded in cell 
culture flasks (flow cytometry) or 24-well 
cell culture plates (intracellular survival and 
proliferation) for 2 h at 37 °C. PAM were 
inoculated with opsonized or non-opsonized 
wild type or ∆sseA Salmonella Typhimurium 
at MOI 10. After 30 min incubation at 37 °C, 
the remaining extracellular bacteria were 
killed by applying cell medium with 100 
µg/ml gentamicin for 1 h at 37°C. 
Subsequently, PAM were washed and 
incubated for 0 h, 6h or 24 h at 37 °C in cell 
medium with 20 µg/ml gentamicin.  
For flowcytometric analysis, 0 and 24 h after 
incubation, PAM were scraped off, 
centrifuged and incubated for 1 h on ice with 
a primary mouse anti-pig SLA class II DQ 
(1:5 dilution; AbD Serotec) or mouse anti-
pig SLA class I (1:50 dilution; AbD Serotec) 
antibody mixture. PAM were washed and 
subsequently incubated for 1 h on ice and in 
the dark with a secondary goat anti-mouse 
Alexa Fluor 633 antibody mixture (1:50 
dilution; Molecular Probes). After a final 
washing step, MHC II expression levels 
were measured using a FACSCanto Flow 
Cytometer (BD Biosciences) and analyzed 
with the FACSDiva Software (BD 
Biosciences). For determination of 
intracellular survival and proliferation of 
 
Salmonella, PAM were lyzed with 1% Triton 
X-100 (Sigma Aldrich) 0 and 6 h after 
infection. Ten-fold dilutions were made, 
plated on BGA (International Medical 
Products) and incubated for 16 h at 37 °C, to 
assess the number of intracellular bacteria.  
 
RESULTS 
The in vivo experiment showed that orally 
inoculated pigs exhibited no seroconversion 
up to 4 weeks post inoculation. To explain 
this phenomenon, we determined Salmonella 
Typhimurium’s ability to downregulate MHC 
II expression on PAM surface to escape the 
humoral immune response. Using 
flowcytometric analysis, we showed that 
MHC II but not MHC I expression was lower 
in infected PAM compared to uninfected 
PAM (Fig. 1A-B). MHC II downregulation 
was at least partly restored when PAM were 
infected with the ∆sseA strain (Fig. 1C-D). 
To determine the impact of antibodies on the 
interaction of Salmonella Typhimurium with 
macrophages, PAM were infected with either 
bacteria opsonized with porcine serum 
containing anti-Salmonella Typhimurium 
antibodies or with negative pig serum. 
Flowcytometric analysis showed that the 
MHC II expression level was completely 
restored to that of uninfected PAM when 
bacteria were opsonized with serum 
containing anti-Salmonella Typhimurium 
antibodies and not after opsonization with 
Salmonella-negative serum (Fig. 1E-F). 
Furthermore, intracellular proliferation of 
wild type Salmonella Typhimurium bacteria 
opsonized with serum containing anti-
Salmonella Typhimurium antibodies was 
significantly impaired compared to that of the 
bacteria opsonized with negative pig serum. 
 
DISCUSSION 
Salmonella Typhimurium has already been 
shown to downregulate antigen presentation 
in murine dendritic cells5. In the present 
study, we showed that Salmonella 
Typhimurium downregulates MHC II but not 
MHC I expression on porcine macrophages in 
a SPI-2 dependent way, showing that 
Salmonella specifically targets MHC II 
expression and thus antibody production. 
Since serum antibodies inhibit MHC II 
 downregulation by and intracellular 
proliferation of Salmonella Typhimurium in 
PAM, it is of great importance for the 
bacterium to circumvent the humoral 
immune response by downregulation of 
MHC II expression. 
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FIGURE 1. The MHC II expression level (FL-5-
A) of uninfected (dark peak) compared to 
Salmonella infected (light peak) PAM. A-B. 
PAM 0 h and 24 h after infection with WT 
Salmonella. C-D. PAM 0 h and 24 h after 
infection with ∆sseA Salmonella. E-F. PAM 0 h 
and 24 h after infection with WT Salmonella 
opsonized with pig serum containing 
Salmonella-specific antibodies. 
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